RVMD · Revolution Medicines, Inc.

$203.71 +1.71 (+0.85%) At close · Aug 14

Market Cap

$43.66B

214.34M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-05	—
10-Q	2026-08-05	2026-06-30
Investor Event Transcript	2026-06-30	—
8-K	2026-06-22	2026-06-18
10-Q	2026-05-06	2026-03-31
8-K	2026-05-06	—
DEF 14A	2026-04-27	2026-06-18
8-K	2026-04-17	2026-04-14
8-K	2026-04-16	2026-04-14
8-K	2026-04-13	—
10-K	2026-02-25	2025-12-31
8-K	2026-02-25	—
8-K	2025-11-05	—
10-Q	2025-11-05	2025-09-30
8-K	2025-10-17	2025-10-16
8-K	2025-09-10	—
10-Q	2025-08-06	2025-06-30
8-K	2025-08-06	—
8-K	2025-06-27	2025-06-26
8-K	2025-06-24	2025-06-23
8-K	2025-06-18	—
8-K	2025-05-07	—
10-Q	2025-05-07	2025-03-31
DEF 14A	2025-04-29	2025-06-26
10-K	2025-02-26	2024-12-31
8-K	2025-02-26	—
8-K	2024-12-05	2024-12-03
8-K	2024-12-02	—
8-K	2024-11-06	—
10-Q	2024-11-06	2024-09-30
8-K	2024-10-25	—
8-K	2024-10-23	—
10-Q	2024-08-07	2024-06-30
8-K	2024-08-07	2024-08-05
8-K	2024-07-15	—
8-K	2024-06-24	2024-06-20
8-K	2024-05-08	—
10-Q	2024-05-08	2024-03-31
DEF 14A	2024-04-25	—
10-K	2024-02-26	2023-12-31
8-K	2024-02-26	—
8-K	2024-01-09	—
8-K/A	2023-12-26	2023-11-08
8-K	2023-11-09	2023-11-08
8-K	2023-11-06	—
10-Q	2023-11-06	2023-09-30
8-K	2023-11-01	—
8-K	2023-10-23	2023-10-22
8-K	2023-10-13	—
8-K	2023-09-05	2023-08-31

Showing 1–50 of 103 filings

Key facts CIK 1628171 CUSIP 76155X100 13F (30d) 642 filings 634 filers Visit website Investor relations